Option Care Health (OPCH) to Post Earnings on Wednesday

Option Care Health (NASDAQ:OPCH) is expected to release its Q2 2026 results before the market opens on Wednesday, July 29th. Analysts expect the company to post earnings of $0.42 per share and revenue of $1.4181 billion for the quarter. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Parties can check the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 8:30 AM ET.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The business had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.39 billion. During the same quarter in the prior year, the business earned $0.40 earnings per share. The company’s quarterly revenue was up 1.3% compared to the same quarter last year. On average, analysts expect Option Care Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $21.81 on Tuesday. The stock has a fifty day moving average price of $21.36 and a 200 day moving average price of $27.01. Option Care Health has a 1-year low of $18.01 and a 1-year high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The company has a market cap of $3.42 billion, a PE ratio of 16.91, a P/E/G ratio of 1.20 and a beta of 0.65.

Analysts Set New Price Targets

A number of brokerages have commented on OPCH. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $26.00 price objective on shares of Option Care Health in a research report on Friday, May 1st. JPMorgan Chase & Co. dropped their price target on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Truist Financial set a $30.00 price target on shares of Option Care Health in a report on Friday, May 1st. TD Cowen reduced their price objective on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating for the company in a research report on Friday, May 1st. Finally, Zacks Research upgraded shares of Option Care Health from a “strong sell” rating to a “hold” rating in a research report on Monday, July 6th. Eight analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $30.08.

Insiders Place Their Bets

In related news, Director Timothy P. Sullivan bought 24,154 shares of the firm’s stock in a transaction on Thursday, May 7th. The shares were bought at an average cost of $20.69 per share, for a total transaction of $499,746.26. Following the transaction, the director owned 73,383 shares of the company’s stock, valued at approximately $1,518,294.27. This trade represents a 49.06% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO John Charles Rademacher purchased 12,500 shares of the stock in a transaction dated Monday, May 4th. The shares were bought at an average cost of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the purchase, the chief executive officer owned 695,152 shares in the company, valued at approximately $14,723,319.36. This trade represents a 1.83% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders have purchased 73,264 shares of company stock worth $1,548,316. Corporate insiders own 1.70% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Royal Bank of Canada lifted its position in shares of Option Care Health by 20.7% during the 1st quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock valued at $8,078,000 after acquiring an additional 39,661 shares during the period. AQR Capital Management LLC grew its holdings in shares of Option Care Health by 162.6% in the 1st quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock worth $1,450,000 after acquiring an additional 25,777 shares during the period. Empowered Funds LLC acquired a new stake in shares of Option Care Health in the 1st quarter worth approximately $208,000. Invesco Ltd. increased its stake in Option Care Health by 2.7% in the 2nd quarter. Invesco Ltd. now owns 294,363 shares of the company’s stock valued at $9,561,000 after purchasing an additional 7,678 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its stake in Option Care Health by 528.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock valued at $46,000 after purchasing an additional 1,183 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.